Principal Financial Group Inc. Purchases 823 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Principal Financial Group Inc. grew its stake in ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,126 shares of the medical instruments supplier’s stock after purchasing an additional 823 shares during the quarter. Principal Financial Group Inc. owned approximately 0.33% of ICU Medical worth $12,461,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Covestor Ltd raised its position in shares of ICU Medical by 86.4% in the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 57 shares during the period. Captrust Financial Advisors raised its position in shares of ICU Medical by 4.5% in the second quarter. Captrust Financial Advisors now owns 1,327 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 57 shares during the period. Moody National Bank Trust Division raised its position in shares of ICU Medical by 1.2% in the fourth quarter. Moody National Bank Trust Division now owns 5,240 shares of the medical instruments supplier’s stock valued at $825,000 after purchasing an additional 63 shares during the period. Yousif Capital Management LLC raised its position in shares of ICU Medical by 0.7% in the fourth quarter. Yousif Capital Management LLC now owns 10,366 shares of the medical instruments supplier’s stock valued at $1,632,000 after purchasing an additional 67 shares during the period. Finally, Credit Suisse AG raised its position in shares of ICU Medical by 0.4% in the third quarter. Credit Suisse AG now owns 21,443 shares of the medical instruments supplier’s stock valued at $3,229,000 after purchasing an additional 87 shares during the period. 93.88% of the stock is owned by institutional investors.

ICU Medical Trading Down 3.9 %

Shares of ICU Medical stock opened at $174.13 on Friday. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of -90.69 and a beta of 0.63. The company has a quick ratio of 1.01, a current ratio of 2.62 and a debt-to-equity ratio of 0.77. ICU Medical, Inc. has a 12-month low of $128.90 and a 12-month high of $212.43. The firm’s 50-day moving average price is $178.12 and its two-hundred day moving average price is $170.69.

ICU Medical (NASDAQ:ICUI – Get Rating) last announced its quarterly earnings data on Monday, February 27th. The medical instruments supplier reported $1.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.14. The firm had revenue of $578.01 million for the quarter, compared to the consensus estimate of $578.60 million. ICU Medical had a negative net margin of 2.00% and a positive return on equity of 6.42%. On average, analysts forecast that ICU Medical, Inc. will post 5.63 earnings per share for the current fiscal year.

Insider Activity

In other news, VP Virginia Ruth Sanzone sold 250 shares of the firm’s stock in a transaction that occurred on Tuesday, April 11th. The shares were sold at an average price of $175.00, for a total value of $43,750.00. Following the sale, the vice president now directly owns 4,678 shares in the company, valued at approximately $818,650. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 7.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. KeyCorp increased their price objective on shares of ICU Medical from $200.00 to $216.00 in a research report on Tuesday, May 9th. 51job reaffirmed a “maintains” rating on shares of ICU Medical in a research report on Tuesday, May 9th. Finally, StockNews.com began coverage on shares of ICU Medical in a research report on Thursday, May 18th. They set a “hold” rating on the stock.

About ICU Medical

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.